An N of One Clinical Trial to Pilot the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment
Withdrawn prior to enrolment
Phase of Trial: Phase 0
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Deferiprone (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 05 Feb 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 21 Aug 2017 Planned End Date changed from 1 Apr 2020 to 1 Apr 2023.
- 21 Aug 2017 Planned primary completion date changed from 1 Apr 2020 to 1 Apr 2022.